Search Results - "Lopes, Mahira"

Germline rare variants in HER2-positive breast cancer predisposition: a systematic review and meta-analysis by de Baumont, Angelica Cerveira, Cadore, Nathan Araujo, Pedrotti, Luana Giongo, Curzel, Giovana Dallaio, Schuch, Jaqueline Bohrer, Bessel, Marina, Bordignon, Cláudia, Rosa, Mahira Lopes, Macedo, Gabriel de Souza, Rosa, Daniela Dornelles

“…Approximately 10% of breast cancer (BC) cases result from hereditary causes. Genetic testing has been widely implemented in BC care to determine hereditary…”
Get full text

Mapping breast and prostate cancer in the Brazilian public health system: study protocol of the Onco-Genomas Brasil by Schuch, Jaqueline Bohrer, Bordignon, Cláudia, Rosa, Mahira Lopes, de Baumont, Angélica Cerveira, Bessel, Marina, Macedo, Gabriel S, Rosa, Daniela Dornelles

“…Breast and prostate cancers are the most common malignancies diagnosed in women and men respectively, and present with great clinical heterogeneity, even in…”
Get full text

The impact of a breast cancer diagnosis on marital outcomes and factors associated with divorce and separation by Werutsky, Gustavo, Lopes, Mahira, de Jesus, Rafaela Gomes, Gazola, Antonia Angeli, Pellegrini, Rodrigo Azevedo, Rebelatto, Taiane Francieli, Freitas, Laura von Wallwitz, Heck, Ana Paula, da Silva, Arthur Ferreira, Rodrigues, Matheus Füehr, Gössling, Gustavo, Giacomazzi, Juliana, Rocha, Matheus Soares, Rosa, Daniela Dornelles, Barrios, Carlos Henrique, Cronemberger, Eduardo Henrique, Queiroz, Geraldo Silva, Bines, José, Simon, Sérgio Daniel, Fay, Andre Poisl

“…To analyze marital outcomes, divorce or separation, and its association with demographic, socioeconomic, and clinicopathological factors among breast cancer…”
Get full text

De-escalation of neoadjuvant therapy for HER2-positive early breast cancer: an overview by Werutsky, Gustavo, Rosa, Mahira Lopes

Get full text

Real-world Data on First-line Systemic Therapy for Hormone Receptor-positive HER2-negative Metastatic Breast Cancer: A Trend Shift in the Era of CDK 4/6 Inhibitors by Werutsky, Gustavo, Reinert, Tomás, Rosa, Mahira Lopes, Barrios, Carlos Henrique

“…Hormone receptor-positive (HR+) human epidermal growth factor receptor-2 negative (HER2–) tumors represent the most common subtype of metastatic breast cancer…”
Get full text

Implications of tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer: clinical oncologist perspectives by Rosa, Mahira Lopes, Reinert, Tomas, Pauletto, Maiane Maria, Sartori, Guilherme, Graudenz, Marcia, Barrios, Carlos Henrique

Get full text

Abstract PS7-89: The socioeconomic impact of breast cancer in Brazil: An analysis of AMAZONA III cohort study by Werutsky, Gustavo, Rosa, Daniela Dornelles, Barrios, Carlos, Cronemberger, Eduardo, Queiroz, Geraldo, Bines, Jose, Rosa, Mahira Lopes, Gomes, Rafaela, Heck, Ana P, Freitas, Laura, da Silva, Arthur F, Rodrigues, Matheus, Fay, Andre P, Simon, Sergio

“…INTRODUCTIONPatients diagnosed with breast cancer (BC) in Brazil are on average 54 years old and the majority (70%) have stage II-III. Age and clinical stage…”
Get full text

Perspectives on the Systemic Staging in Newly Diagnosed Breast Cancer by Reinert, Tomás, de Souza, Alessandra Borba Anton, Rosa, Mahira Lopes, Bedin, Sabrina Richter, Barrios, Carlos Henrique

“…Breast cancer is a complex disease, and accurate systemic staging is an essential aspect of the evaluation of a patient with newly diagnosed breast cancer…”
Get full text

Abstract PO5-17-12: Impact of HER2-low status on axillary response and surgical management after neoadjuvant chemotherapy in early breast cancer by da Silva, Leonardo Roberto, Sartori, Guilherme, Ramalho, Susana, Reinert, Tomás, Da Rosa, Mahira Lopes, Tavares, Grazielle Morais, Mantovani, Higor, Vasconcelos, Vivian, Cabello, Ana Elisa Ribeiro Da Silva, Coelho, Guilherme, Mandelli, Jovana, Zaffaroni, Facundo, Barrios, Carlos, Graudenz, Marcia Silveira, Cabello, César

“…Background: Breast cancer (BC) with low expression of HER2 (HER2-low) might constitute a group of tumors with unique clinical and biological characteristics…”
Get full text

Abstract PO5-17-09: Event-free survival in HER2-low vs HER2-zero breast cancer patients submitted to neoadjuvant chemotherapy by Sartori, Guilherme, Ramalho, Susana, da Silva, Leonardo Roberto, Reinert, Tomás, Da Rosa, Mahira Lopes, Tavares, Grazielle Morais, Vasconcelos, Vivian, Mantovani, Higor, Cabello, Ana Elisa Ribeiro Da Silva, Coelho, Guilherme, Mandelli, Jovana, Zaffaroni, Facundo, Cabello, César, Barrios, Carlos, Graudenz, Marcia Silveira

“…Background: Breast cancer (BC) with low expression of HER2 (HER2-low) might constitute a group of tumors with unique clinical and biological characteristics…”
Get full text